News Monoclonal Antibodies Make Headway in Sjögren Treatment by Medscape • 2024/08/05 • 0 Comments Positive results were reported from the DAHLIAS study of nipocalimab, the TWINSS study of iscalimab, and a phase 1 trial of tibulizumab, but it was negative news for lusvertikimab. Medscape Medical News